CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Xilio Therapeutics, Inc.

XLO
$59MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for XLO. That does not mean none is planned.

Get an email about XLO's next catalysts

Track Xilio Therapeutics (XLO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 2 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaWALTHAM64 employees
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Xilio Therapeutics, Inc.'s drug pipeline?β†’

CatalystAlert tracks 4 drug candidates in Xilio Therapeutics, Inc.'s (XLO) pipeline across Phase 2. Its lead program is vilastobart (XTX101) (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Xilio Therapeutics, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Xilio Therapeutics, Inc. (XLO) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track XLO biotech catalysts?β†’

Add XLO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Xilio Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply